The Mortimer B. Zuckerman Research Center, a key component of the Sloan Kettering Institute, is a prominent medical center located in New York, New York. Situated at 417 East 68th Street, this facility serves as a hub for cutting-edge research and clinical innovation in cancer treatment and biomedical sciences. It supports a range of specialized research programs aimed at advancing understanding of cancer biology, developing new therapeutic strategies, and improving patient outcomes.
As part of the larger Memorial Sloan Kettering Cancer Center network, the Mortimer B. Zuckerman Research Center integrates basic science with clinical applications, fostering collaboration among scientists, clinicians, and graduate students. The center also houses the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, providing an environment where education and research intersect to train future leaders in biomedical research and medicine. This integration ensures that discoveries made in the laboratory can be rapidly translated into effective medical treatments.
The center’s focus on medical research spans multiple disciplines, including molecular biology, immunology, genetics, and drug development. By concentrating on these areas, the center contributes to the broader mission of the Sloan Kettering Institute to combat cancer through innovative science and patient-centered care. With its advanced facilities and interdisciplinary teams, the Mortimer B. Zuckerman Research Center remains a vital institution within the New York medical community, dedicated to improving health outcomes through rigorous research and education.
Residents of New York and surrounding areas seeking expert medical research collaboration or advanced cancer treatment options often turn to this center for its comprehensive resources and expertise. Contact can be made via phone at 212-639-2000 for more information about the center’s programs and services.
